miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.
about
Transglutaminase is a tumor cell and cancer stem cell survival factormiR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-MetMicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1.A panel of microRNA signature in serum for colorectal cancer diagnosis.TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated AutophagyInvolvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.The role of microRNAs in colorectal liver metastasis: Important participants and potential clinical significances.Tissue transglutaminase 2 exerts a tumor-promoting role in hepatitis B virus-related hepatocellular carcinoma.Transcriptional downregulation of microRNA-19a by ROS production and NF-κB deactivation governs resistance to oxidative stress-initiated apoptosis.Effect of p53 on pancreatic cancer-glucose tolerance abnormalities by regulating transglutaminase 2 in resistance to glucose metabolic stress.Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression.Development of Novel Monoclonal Antibodies for Evaluation of Transmembrane Prostate Androgen-Induced Protein 1 (TMEPAI) Expression Patterns in Gastric Cancer.miR-19a promotes colitis-associated colorectal cancer by regulating tumor necrosis factor alpha-induced protein 3-NF-κB feedback loops.Prognostic role of tissue transglutaminase 2 in colon carcinoma.microRNA biomarkers in colorectal cancer liver metastasisThe emerging role of miR-19 in glioma
P2860
Q26799862-4897F3EE-7FDC-45D0-BD40-BFD6DDB8EFBDQ33774131-6EE4D6AD-CB28-40B0-9C31-DF86E4EE240FQ33829355-9060DBCD-4920-4970-A8F5-9ED9CAC740E2Q37680137-17FD8F40-872D-4594-8056-0806099BA8E8Q37725573-32D4F37E-DE34-4F4A-B03C-FBB3133F7ABFQ38734433-9D9CEAE8-7FDE-475F-B4CF-68E3403DB918Q38940586-302E0C4C-3D81-47A0-99FB-ABF932EC585BQ39398929-A52BFA80-9153-4488-B555-002EA8F0E232Q40484496-2DECCC70-2256-482E-8490-826A338A52A2Q42378496-CCE052CC-CB5F-4F5A-A1B4-2AAD7C17A2F6Q46271434-3989683B-A59E-4A5D-A530-C3EA48486D35Q47239489-8C088D80-832C-4CD5-AD24-8B8B0CB95CD5Q50205607-40DE8E5A-F420-4B4A-A8DB-6232E4461AA5Q51251429-F6664119-DCD7-4A17-B64E-4F820C8150BCQ51515881-7F13FE43-88E3-43F0-B40F-A06A2A48C9CDQ58581359-2FC50AF7-E549-4F2F-ABE1-EE98953B7845Q58802654-9C152AD7-4A78-4640-A63D-D54A13FC26CC
P2860
miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
miR-19-Mediated Inhibition of ...... tastasis in Colorectal Cancer.
@en
type
label
miR-19-Mediated Inhibition of ...... tastasis in Colorectal Cancer.
@en
prefLabel
miR-19-Mediated Inhibition of ...... tastasis in Colorectal Cancer.
@en
P2093
P2860
P1476
miR-19-Mediated Inhibition of ...... tastasis in Colorectal Cancer.
@en
P2093
A H Mirnezami
G J Thomas
J C Strefford
S Quaratino
P2860
P304
P356
10.1158/1541-7786.MCR-14-0466
P577
2015-05-01T00:00:00Z